EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytoprotective Effects of Agomelatine on Hepatic Ischemia–Reperfusion Injury in a Rat Model

Yilmaz Bilgic, Sami Akbulut iD, Oguzhan Yildirim, Onural Ozhan iD, Azibe Yildiz iD, Zeynep Erdemli, Mehmet Erman Erdemli, Adem Kose iD, Nigar Vardi, Yusuf Turkoz iD, Hakan Parlakpinar iD

International Journal of Molecular Sciences · 02.04.2026 · 27 (7) · 3246

DOI: 10.3390/ijms27073246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.04.2026. Verfasst von Yilmaz Bilgic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye. Hauptthemen laut MEDLINE: Reperfusion Injury, Acetamides, Liver, Cytoprotection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inonu University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic ischemia–reperfusion injury (IRI) is a major cause of liver damage and is characterized by oxidative stress, inflammatory signaling, and hepatocellular apoptosis. Aim: This study investigated the hepatoprotective effects of agomelatine (AGO) administered before ischemia or at the onset of reperfusion in a hepatic IRI model. Rats were allocated into four experimental groups: Sham, IRI, IRI+AGO, and AGO+IRI. Hepatic ischemia was induced by clamping the hepatic pedicle for 1 h followed by 1 h of reperfusion. AGO (20 mg/kg) was administered orally either before ischemia or at the onset of reperfusion. Oxidative stress markers, antioxidant enzymes, nitric-oxide-related parameters, cytokines, liver injury enzymes, and histopathological changes were evaluated. IRI increased oxidant markers and reduced antioxidant defenses. AGO treatment improved redox balance and antioxidant parameters in both treatment groups, with stronger antioxidant responses observed in the AGO+IRI group. Nitric oxide (NO)-related markers differed among groups, including changes in L-arginine, asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA) levels, and interleukin-6 (IL-6) levels decreased following AGO administration, particularly in the AGO+IRI group. Histopathological injury and caspase-3 expression were also attenuated in AGO-treated animals. AGO attenuates hepatic IRI by improving redox balance, modulating NO metabolism, and reducing IL-6–associated signaling and apoptosis, with stronger protection when administered before ischemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryAcetamidesLiverCytoprotectionLiver DiseasesAnimalsNaphthalenesRatsMaleOxidative StressAntioxidantsDisease Models, AnimalNitric OxideApoptosisCaspase 3

Stichwörter der Autor:innen

agomelatineantioxidant capacityapoptosisinflammationischemia–reperfusion injuryliveroxidative stress

Substanzen

agomelatineNaphthalenesAcetamidesAntioxidantsNitric OxideCaspase 3

Autor:innen und Institutionen

  • Department of Gastroenterology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Surgery, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Pharmacology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Histology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Biochemistry, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.

ORCID-Profile: Sami Akbulut, Onural Ozhan, Azibe Yildiz, Adem Kose, Yusuf Turkoz, Hakan Parlakpinar

Förderung

  • Inonu University Scientific Research Projects Coordination Unit

Zitieren

APA

Bilgic, Y., Akbulut, S., Yildirim, O., Ozhan, O., Yildiz, A., Erdemli, Z., Erdemli, M. E., Kose, A., Vardi, N., Turkoz, Y., & Parlakpinar, H. (2026). Cytoprotective Effects of Agomelatine on Hepatic Ischemia–Reperfusion Injury in a Rat Model. International Journal of Molecular Sciences, 27(7), 3246. https://doi.org/10.3390/ijms27073246

Vancouver

Bilgic Y, Akbulut S, Yildirim O, Ozhan O, Yildiz A, Erdemli Z, et al. Cytoprotective Effects of Agomelatine on Hepatic Ischemia–Reperfusion Injury in a Rat Model. International Journal of Molecular Sciences. 2026;27(7):3246. doi:10.3390/ijms27073246

BibTeX
@article{Bilgic2026,
  author = {Bilgic, Yilmaz and Akbulut, Sami and Yildirim, Oguzhan and Ozhan, Onural and Yildiz, Azibe and Erdemli, Zeynep and Erdemli, Mehmet Erman and Kose, Adem and Vardi, Nigar and Turkoz, Yusuf and Parlakpinar, Hakan},
  title = {Cytoprotective Effects of Agomelatine on Hepatic Ischemia–Reperfusion Injury in a Rat Model},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3246},
  doi = {10.3390/ijms27073246}
}
Kostenlos starten →